OSLER WEBER RENDU DISEASE

Clinical trials for OSLER WEBER RENDU DISEASE explained in plain language.

Never miss a new study

Get alerted when new OSLER WEBER RENDU DISEASE trials appear

Sign up with your email to follow new studies for OSLER WEBER RENDU DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

Could a common heart drug tame nosebleeds in a rare bleeding disorder?

Symptom relief Completed

This study looked at whether propranolol, a beta-blocker usually used for heart conditions, can help people with hereditary hemorrhagic telangiectasia (HHT) who have frequent nosebleeds. Fifteen adults with HHT took propranolol for three months. The main goal was to see if the to…

Matched conditions: OSLER WEBER RENDU DISEASE

Phase: PHASE3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief

Last updated May 26, 2026 12:12 UTC

OSLER WEBER RENDU DISEASE

Get alerted when new OSLER WEBER RENDU DISEASE trials appear

Could a common heart drug tame nosebleeds in a rare bleeding disorder?